Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 2
1995 3
1996 4
1997 3
1998 2
1999 4
2000 3
2001 3
2002 4
2003 5
2004 4
2005 3
2006 4
2008 5
2009 5
2010 2
2011 4
2012 7
2013 7
2014 6
2015 6
2016 6
2017 10
2018 7
2019 12
2020 5
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
Sex disparities matter in cancer development and therapy.
Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Haupt S, et al. Among authors: haupt y. Nat Rev Cancer. 2021 Jun;21(6):393-407. doi: 10.1038/s41568-021-00348-y. Epub 2021 Apr 20. Nat Rev Cancer. 2021. PMID: 33879867 Free PMC article. Review.
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.
Agupitan AD, Neeson P, Williams S, Howitt J, Haupt S, Haupt Y. Agupitan AD, et al. Among authors: haupt y. Int J Mol Sci. 2020 May 13;21(10):3452. doi: 10.3390/ijms21103452. Int J Mol Sci. 2020. PMID: 32414156 Free PMC article. Review.
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
AbuHammad S, Cullinane C, Martin C, Bacolas Z, Ward T, Chen H, Slater A, Ardley K, Kirby L, Chan KT, Brajanovski N, Smith LK, Rao AD, Lelliott EJ, Kleinschmidt M, Vergara IA, Papenfuss AT, Lau P, Ghosh P, Haupt S, Haupt Y, Sanij E, Poortinga G, Pearson RB, Falk H, Curtis DJ, Stupple P, Devlin M, Street I, Davies MA, McArthur GA, Sheppard KE. AbuHammad S, et al. Among authors: haupt y. Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17990-18000. doi: 10.1073/pnas.1901323116. Epub 2019 Aug 22. Proc Natl Acad Sci U S A. 2019. PMID: 31439820 Free PMC article.
Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Mansour M, Haupt S, Chan AL, Godde N, Rizzitelli A, Loi S, Caramia F, Deb S, Takano EA, Bishton M, Johnstone C, Monahan B, Levav-Cohen Y, Jiang YH, Yap AS, Fox S, Bernard O, Anderson R, Haupt Y. Mansour M, et al. Among authors: haupt y. Cancer Res. 2019 Jun 1;79(11):3008. doi: 10.1158/0008-5472.CAN-19-1133. Cancer Res. 2019. PMID: 31160311 Free article. No abstract available.
Mdm2 promotes the rapid degradation of p53.
Haupt Y, Maya R, Kazaz A, Oren M. Haupt Y, et al. Nature. 1997 May 15;387(6630):296-9. doi: 10.1038/387296a0. Nature. 1997. PMID: 9153395
Clinical Overview of MDM2/X-Targeted Therapies.
Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y, Lim E. Burgess A, et al. Among authors: haupt y. Front Oncol. 2016 Jan 27;6:7. doi: 10.3389/fonc.2016.00007. eCollection 2016. Front Oncol. 2016. PMID: 26858935 Free PMC article. Review.
The long and the short of it: the MDM4 tail so far.
Haupt S, Mejía-Hernández JO, Vijayakumaran R, Keam SP, Haupt Y. Haupt S, et al. Among authors: haupt y. J Mol Cell Biol. 2019 Mar 1;11(3):231-244. doi: 10.1093/jmcb/mjz007. J Mol Cell Biol. 2019. PMID: 30689920 Free PMC article. Review.
Regulation of Mutant p53 Protein Expression.
Vijayakumaran R, Tan KH, Miranda PJ, Haupt S, Haupt Y. Vijayakumaran R, et al. Among authors: haupt y. Front Oncol. 2015 Dec 17;5:284. doi: 10.3389/fonc.2015.00284. eCollection 2015. Front Oncol. 2015. PMID: 26734569 Free PMC article. Review.
123 results